📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy. (2012)

First Author: Pincha M
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/hgtb.2011.170

PubMed Identifier: 22428979

Publication URI: http://europepmc.org/abstract/MED/22428979

Type: Journal Article/Review

Volume: 23

Parent Publication: Human gene therapy methods

Issue: 1

ISSN: 1946-6536